American Drug Utilizations Review Society
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 154,761 | 184,347 | −29,586 | 25.0 | 16% |
| 2013 | 153,327 | 168,117 | −14,790 | 26.3 | 15% |
| 2014 | 248,116 | 194,692 | 53,424 | 26.0 | 14% |
| 2015 | 267,104 | 205,675 | 61,429 | 28.2 | 16% |
| 2016 | 250,553 | 207,609 | 42,944 | 29.4 | 16% |
| 2017 | 262,930 | 210,335 | 52,595 | 33.1 | 15% |
| 2018 | 229,963 | 201,758 | 28,205 | 37.2 | 8% |
| 2019 | 238,192 | 225,757 | 12,435 | 33.7 | 7% |
| 2020 | 238,249 | 205,264 | 32,985 | 36.5 | 7% |
| 2021 | 71,209 | 108,672 | −37,463 | 76.4 | 25% |
| 2022 | 250,239 | 230,138 | 20,101 | 33.8 | 6% |
| 2023 | 237,818 | 346,779 | −108,961 | 18.1 | 7% |
| 2024 | 258,062 | 232,870 | 25,192 | 29.6 | 11% |
In its most recent public year (2024), this organization brought in $25,192 more than it spent. Its reserves stood at about 29.6 months of spending, up from 25 in 2012. Staff pay was 11% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works